Haemovigilance (HV) comprises surveillance procedures covering the whole transfusion chain from collection of blood (components) to follow-up of its recipients. It assesses information on undesirable transfusion effects to prevent their occurrence. This includes local venepuncture accidents, iron depletion, graft vs. host disease and mild to severe transfusion reactions. The HV definitions aim to standardize and report all these events in order to improve blood safety.
The WP focuses on both recipients and donors. We develop definitions and tools and share and compare data. We regularly discuss updates on international activities and work on definitions and tools. We collaborate with HV organisations across the world.
Our Chairperson is Kevin Land.
We have one shared subgroup, the Paediatric Subgroup of the Clinical Transfusion and the Haemovigilance Working Party (chaired by Gemma Crighton). This subgroup has a particular interest in neonatal and paediatric transfusion adverse events, reporting and definitions. Click here to navigate to the Paediatrics Subgroup webpage.
We meet at the ISBT congresses and develop HV definitions and tools. We also participate in international projects and have regular discussions with other Working Parties.
Any professional who is actively involved in HV at any level is able to join this WP. Pharmaceutical company employees are able to join only if they contribute from a technical and scientific point of view, are transparent about their affiliation and do not promote any products.
Interested in joining the Haemovigilance WP? Please email our Chairperson.
Some of the content is only accessible for ISBT-members. To join us, click here.
Follow this link to visit ISBT Education and watch the webcast of Gwen Clarke. The talk was recorded at the 34th International Congress of the ISBT in Dubai.